CCR9 inhibitors (Cubist Pharmaceuticals)

N/A

Report date: 2025/03/19 09:01:33
NME

Base Information

Drug NameCCR9 inhibitors (Cubist Pharmaceuticals)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-C chemokine receptor type 9 antagonists
TargetsC-C chemokine receptor type 9
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCubist Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesMerck & Co Inc
Inactive CompaniesCubist Pharmaceuticals Inc
Active IndicationsInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A